China SXT Pharmaceuticals, Inc.
Price Action
Technical Summary
WEAKENINGChina SXT Pharmaceuticals, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 13), showing significant lag compared to the market leaders. Earnings contraction of 119% provides fundamental context to the price action. However, price is extended 27% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $2.04 | +18.89% | ABOVE |
| 50 SMA | $1.90 | +27.20% | ABOVE |
| 100 SMA | $2.03 | +19.15% | ABOVE |
| 150 SMA | $53.26 | -95.46% | BELOW |
| 200 SMA | $97.66 | -97.52% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is SXTC in an uptrend right now?
SXTC has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is SXTC overbought or oversold?
SXTC's RSI (14) is 59. The stock is in neutral territory, neither overbought nor oversold.
Is SXTC outperforming the market?
SXTC has a Relative Strength (RS) Rating of 13 out of 99. SXTC is currently lagging the broader market.
Where is SXTC in its 52-week range?
SXTC is trading at $2.42, which is 0% of its 52-week high ($1046.98) and 0% above its 52-week low ($0.08).
How volatile is SXTC?
SXTC has a Beta of 1.11 and 52-week volatility of 191%. It's more volatile than the S&P 500 - expect bigger swings.